Abstract
Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease characterized by the formation of protein inclusion and progressive loss of motor neurons, finally leading to muscle weakness and respiratory failure. So far, the effective drugs for ALS are yet to be developed. Impairment of transcriptional activator transcription factor EB (TFEB) has been demonstrated as a key element in the pathogenesis of ALS. Trehalose is an mechanistic target of rapamycin-independent inducer for autophagy, which showed autophagic activation and neuroprotective effect in a variety of neurodegenerative diseases. The mechanism for trehalose-induced autophagy enhancement is not clear, and its therapeutic effect on TAR DNA-binding protein-43 (TDP-43) proteinopathies has been poorly investigated. Here we examined the effect of trehalose on TDP-43 clearance in a cell culture model and identified that trehalose treatment significantly reduced TDP-43 accumulation in vitro through modulation of the autophagic degradation pathway. Further studies revealed that activation of TFEB induced by trehalose was responsible for the enhancement of autophagy and clearance of TDP-43 level. These results gave us the notion that TFEB is a central regular in trehalose-mediated autophagic clearance of TDP-43 aggregates, representing an important step forward in the treatment of TDP-43 related ALS diseases.
Similar content being viewed by others
References
Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351(3):602–611. https://doi.org/10.1016/j.bbrc.2006.10.093
Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, Kordasiewicz HB, McAlonis-Downes M, Platoshyn O, Parone PA, Da Cruz S, Clutario KM, Swing D, Tessarollo L, Marsala M, Shaw CE, Yeo GW, Cleveland DW (2013) ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A 110(8):E736–E745. https://doi.org/10.1073/pnas.1222809110
Barreca D, Lagana G, Ficarra S, Tellone E, Leuzzi U, Magazu S, Galtieri A, Bellocco E (2010) Anti-aggregation properties of trehalose on heat-induced secondary structure and conformation changes of bovine serum albumin. Biophys Chem 147(3):146–152. https://doi.org/10.1016/j.bpc.2010.01.010
Chang CF, Lee YC, Lee KH, Lin HC, Chen CL, Shen CJ, Huang CC (2016) Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J Biomed Sci 23(1):72. https://doi.org/10.1186/s12929-016-0290-z
Chen Y, Liu H, Guan Y, Wang Q, Zhou F, Jie L, Ju J, Pu L, Du H, Wang X (2015) The altered autophagy mediated by TFEB in animal and cell models of amyotrophic lateral sclerosis. Am J Transl Res 7(9):1574–1587
Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A 110(19):E1817–E1826. https://doi.org/10.1073/pnas.1305623110
Dehay B, Bove J, Rodriguez-Muela N, Perier C, Recasens A, Boya P, Vila M (2010) Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 30(37):12535–12544. https://doi.org/10.1523/jneurosci.1920-10.2010
Di Meco A, Li JG, Blass BE, Abou-Gharbia M, Lauretti E, Pratico D (2017) 12/15-Lipoxygenase inhibition reverses cognitive impairment, brain amyloidosis, and tau pathology by stimulating autophagy in aged triple transgenic mice. Biol Psychiatry 81(2):92–100. https://doi.org/10.1016/j.biopsych.2016.05.023
Dimasi P, Quintiero A, Shelkovnikova TA, Buchman VL (2017) Modulation of p-eIF2α cellular levels and stress granule assembly/disassembly by trehalose. Sci Rep 7:44088. https://doi.org/10.1038/srep44088
Ghavami S, Sharma P, Yeganeh B, Ojo OO, Jha A, Mutawe MM, Kashani HH, Los MJ, Klonisch T, Unruh H, Halayko AJ (2014) Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. Biochim Biophys Acta 1843(7):1259–1271. https://doi.org/10.1016/j.bbamcr.2014.03.006
Harris H, Rubinsztein DC (2012) Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol 8(2):108–117
He Q, Wang Y, Lin W, Zhang Q, Zhao J, Liu FT, Tang YL, Xiao BG, Wang J (2014) Trehalose alleviates PC12 neuronal death mediated by lipopolysaccharide-stimulated BV-2 cells via inhibiting nuclear transcription factor NF-kappaB and AP-1 activation. Neurotox Res 26(4):430–439. https://doi.org/10.1007/s12640-014-9487-7
Holler CJ, Taylor G, McEachin ZT, Deng Q, Watkins WJ, Hudson K, Easley CA, Hu WT, Hales CM, Rossoll W, Bassell GJ, Kukar T (2016) Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Mol Neurodegener 11(1):46. https://doi.org/10.1186/s13024-016-0114-3
Jangamreddy JR, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson BA, Rao Pariti RK, Cieslar-Pobuda A, Panigrahi S, Los MJ (2013) Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells. Biochim Biophys Acta 1833(9):2057–2069. https://doi.org/10.1016/j.bbamcr.2013.04.011
Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M, Stafa K, Lee HJ, Lee SJ, Masliah E (2015) Antagonizing neuronal toll-like receptor 2 prevents Synucleinopathy by activating autophagy. Cell Rep 13(4):771–782. https://doi.org/10.1016/j.celrep.2015.09.044
Kimura S, Noda T, Yoshimori T (2007) Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3(5):452–460. https://doi.org/10.4161/auto.4451
Leblond CS, Kaneb HM, Dion PA, Rouleau GA (2014) Dissection of genetic factors associated with amyotrophic lateral sclerosis. Exp Neurol 262(Pt B):91–101. https://doi.org/10.1016/j.expneurol.2014.04.013
Lee EB, Lee VMY, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13(1):38–50
Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H, Li C (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience 298:12–25. https://doi.org/10.1016/j.neuroscience.2015.03.061
Maekawa S, Leigh PN, King A, Jones E, Steele JC, Bodi I, Shaw CE, Hortobagyi T, Al-Sarraj S (2009) TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology 29(6):672–683. https://doi.org/10.1111/j.1440-1789.2009.01029.x
Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140(3):313–326. https://doi.org/10.1016/j.cell.2010.01.028
Nalbandian A, Llewellyn KJ, Nguyen C, Yazdi PG, Kimonis VE (2015) Rapamycin and chloroquine: the in vitro and in vivo effects of autophagy-modifying drugs show promising results in valosin containing protein multisystem proteinopathy. PLoS One 10(4):e0122888. https://doi.org/10.1371/journal.pone.0122888
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, NY) 314(5796):130–133. https://doi.org/10.1126/science.1134108
Oliver AE, Jamil K, Crowe JH, Tablin F (2004) Loading human mesenchymal stem cells with trehalose by fluid-phase endocytosis. Cell Preserv Technol 2(1):35–49. https://doi.org/10.1089/153834404322708745
Pagliassotti MJ, Estrada AL, Hudson WM, Wei Y, Wang D, Seals DR, Zigler ML, LaRocca TJ (2017) Trehalose supplementation reduces hepatic endoplasmic reticulum stress and inflammatory signaling in old mice. J Nutr Biochem 45:15–23. https://doi.org/10.1016/j.jnutbio.2017.02.022
Pallet N, Legendre C (2013) Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 12(2):177–186. https://doi.org/10.1517/14740338.2013.752814
Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, Chaudhury A, Bajaj L, Bondar VV, Bremner L, Saleem U, Tse DY, Sanagasetti D, Wu SM, Neilson JR, Pereira FA, Pautler RG, Rodney GG, Cooper JD, Sardiello M (2017) mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8:14338. https://doi.org/10.1038/ncomms14338
Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M (2012) Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-beta precursor protein. Mol Cell Biol 32(21):4410–4418. https://doi.org/10.1128/mcb.00930-12
Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci 9:68. https://doi.org/10.3389/fnagi.2017.00068
Polito VA, Li H, Martini-Stoica H, Wang B, Yang L, Xu Y, Swartzlander DB, Palmieri M, di Ronza A, Lee VM, Sardiello M, Ballabio A, Zheng H (2014) Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med 6(9):1142–1160. https://doi.org/10.15252/emmm.201303671
Ravikumar B, Duden R, Rubinsztein DC (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11(9):1107–1117. https://doi.org/10.1093/hmg/11.9.1107
Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36(6):585–595. https://doi.org/10.1038/ng1362
Richards AB, Krakowka S, Dexter LB, Schmid H, Wolterbeek AP, Waalkens-Berendsen DH, Shigoyuki A, Kurimoto M (2002) Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem tToxicol 40(7):871–898. https://doi.org/10.1016/S0278-6915(02)00011-X
Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM (2012) The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5(228):ra42. https://doi.org/10.1126/scisignal.2002790
Rodriguez-Arribas M, Yakhine-Diop SM, Gonzalez-Polo RA, Niso-Santano M, Fuentes JM (2017) Turnover of lipidated LC3 and autophagic cargoes in mammalian cells. Methods Enzymol 587:55–70. https://doi.org/10.1016/bs.mie.2016.09.053
Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, Ballabio A (2009) A gene network regulating lysosomal biogenesis and function. Science (New York, NY) 325:473–477. https://doi.org/10.1126/science.1174447
Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282(8):5641–5652. https://doi.org/10.1074/jbc.M609532200
Scotter EL, Vance C, Nishimura AL, Lee YB, Chen HJ, Urwin H, Sardone V, Mitchell JC, Rogelj B, Rubinsztein DC, Shaw CE (2014) Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J Cell Sci 127(6):1263–1278. https://doi.org/10.1242/jcs.140087
Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A (2011) TFEB links autophagy to lysosomal biogenesis. Science (New York, NY) 332(6036):1429–1433. https://doi.org/10.1126/science.1204592
Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31(5):1095–1108. https://doi.org/10.1038/emboj.2012.32
Settembre C, Fraldi A, Medina DL, Ballabio A (2013) Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14(5):283–296. https://doi.org/10.1038/nrm3565
Shin HJ, Kim H, Oh S, Lee JG, Kee M, Ko HJ, Kweon MN, Won KJ, Baek SH (2016) AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534(7608):553–557. https://doi.org/10.1038/nature18014
Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1alpha rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4(142):142ra197. https://doi.org/10.1126/scitranslmed.3003799
Uchida K, Unuma K, Funakoshi T, Aki T, Uemura K (2014) Activation of master autophagy regulator TFEB during systemic LPS administration in the cornea. J Toxicol Pathol 27(2):153–158. https://doi.org/10.1293/tox.2014-0004
Urushitani M, Sato T, Bamba H, Hisa Y, Tooyama I (2010) Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP-43. J Neurosci Res 88:784–797. https://doi.org/10.1002/jnr.22243
Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science (New York, NY) 323(5918):1208–1211. https://doi.org/10.1126/science.1165942
Vodicka P, Chase K, Iuliano M, Tousley A, Valentine DT, Sapp E, Kegel-Gleason KB, Sena-Esteves M, Aronin N, DiFiglia M (2016) Autophagy activation by transcription factor EB (TFEB) in striatum of HDQ175/Q7 mice. J Huntington's Dis 5(3):249–260. https://doi.org/10.3233/jhd-160211
Wang Q, Ren J (2016) mTOR-independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: role of p38 MAPK and Foxo1. Pharmacol Res 111:357–373. https://doi.org/10.1016/j.phrs.2016.06.024
Wang X, Fan H, Ying Z, Li B, Wang H, Wang G (2010) Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci Lett 469(1):112–116. https://doi.org/10.1016/j.neulet.2009.11.055
Wang H, Wang R, Xu S, Lakshmana MK (2016) Transcription factor EB is selectively reduced in the nuclear fractions of Alzheimer’s and amyotrophic lateral sclerosis brains. Neurosci J 2016:1–8. https://doi.org/10.1155/2016/4732837
Wolkers WF, Walker NJ, Tablin F, Crowe JH (2001) Human platelets loaded with trehalose survive freeze-drying. Cryobiology 42(2):79–87. https://doi.org/10.1006/cryo.2001.2306
Xia Q, Wang H, Hao Z, Fu C, Hu Q, Gao F, Ren H, Chen D, Han J, Ying Z, Wang G (2016) TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion. EMBO J 35:121–142. https://doi.org/10.15252/embj.201591998
Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, Gonzales E, Burchett JM, Schuler DR, Cirrito JR, Diwan A, Lee JM (2014) Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis. J Neurosci 34(29):9607–9620. https://doi.org/10.1523/jneurosci.3788-13.2014
Yu WB, Jiang T, Lan DM, Lu JH, Yue ZY, Wang J, Zhou P (2012) Trehalose inhibits fibrillation of A53T mutant alpha-synuclein and disaggregates existing fibrils. Arch Biochem Biophys 523(2):144–150. https://doi.org/10.1016/j.abb.2012.04.021
Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L, Le W (2014) MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 10(4):588–602. https://doi.org/10.4161/auto.27710
Acknowledgments
This work was supported by grants to Jian Wang from the National Natural Science Foundation of China (81571232 and 81371413) and project (2016YFC1306500) from the Ministry of Science and Technology of China, and grants to Feng-Tao Liu from Scientific Research Project (2016QD01) from Huashan Hospital affiliated to Fudan University. The authors wish to express their gratitude to Professor Jin Xu and his laboratory members for their guidance and technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Wang, Y., Liu, FT., Wang, YX. et al. Autophagic Modulation by Trehalose Reduces Accumulation of TDP-43 in a Cell Model of Amyotrophic Lateral Sclerosis via TFEB Activation. Neurotox Res 34, 109–120 (2018). https://doi.org/10.1007/s12640-018-9865-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12640-018-9865-7